Capecitabine and Oxaliplatin (XELOX) for the Treatment of Patients with Metastatic Gastric Cancer and Severe Liver Dysfunction

Gastric cancer patients with severe liver dysfunction secondary to hepatic metastases have limited treatment options. Most cytotoxic drugs have a narrow therapeutic index. Although both capecitabine and oxaliplatin have been well tolerated as single agents for patients with severe hepatic dysfunctio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Seung Jae, Park, Jong Won, Lee, Sehe Dong, Kim, Gyong Jung, Sin, Cheol Ho, Nam, Seung-Hyun, Kim, Bong-Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2006
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891032/
https://www.ncbi.nlm.nih.gov/pubmed/17249509
http://dx.doi.org/10.3904/kjim.2006.21.4.252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891032/
https://www.ncbi.nlm.nih.gov/pubmed/17249509
http://dx.doi.org/10.3904/kjim.2006.21.4.252

Ejemplares similares